R. Sadun, A. Eudy, Jennifer L Rogers, K. Sun, Karissa Grier, E. Scarlett, Mithu Maheswaranathan, Lisa G. Criscione-Schreiber, J. Doss, M. Clowse
{"title":"1205 COVID-19 vaccine beliefs amongst individuals living with lupus","authors":"R. Sadun, A. Eudy, Jennifer L Rogers, K. Sun, Karissa Grier, E. Scarlett, Mithu Maheswaranathan, Lisa G. Criscione-Schreiber, J. Doss, M. Clowse","doi":"10.1136/lupus-2021-lupus21century.72","DOIUrl":null,"url":null,"abstract":"1205 Figure 1Respondents indicated which factors would have a positive influence on their likelihood of getting vaccinated against COVID-19;more than two-thirds of respondents indicated they would be more likely to pursue vaccination if they were presented with evidence of COVID-19 vaccine safety in lupus.[Figure omitted. See PDF]ConclusionsThese results indicate an opportunity for healthcare professionals and patient advocacy organizations to assuage unfounded patient concerns, such as vaccine interactions with medications or food allergies being a contraindication to COVID-19 vaccination, while reassuring patients that vaccine-triggered flares are rare.AcknowledgementWe would like to thank the Lupus Foundation of American for their partnership in this research.","PeriodicalId":263566,"journal":{"name":"1200 - COVID-19","volume":"137 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"1200 - COVID-19","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/lupus-2021-lupus21century.72","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
1205 Figure 1Respondents indicated which factors would have a positive influence on their likelihood of getting vaccinated against COVID-19;more than two-thirds of respondents indicated they would be more likely to pursue vaccination if they were presented with evidence of COVID-19 vaccine safety in lupus.[Figure omitted. See PDF]ConclusionsThese results indicate an opportunity for healthcare professionals and patient advocacy organizations to assuage unfounded patient concerns, such as vaccine interactions with medications or food allergies being a contraindication to COVID-19 vaccination, while reassuring patients that vaccine-triggered flares are rare.AcknowledgementWe would like to thank the Lupus Foundation of American for their partnership in this research.